Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

216.26 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
85 86 Next >
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
3 No-Brainer Dividend Stocks to Buy in September
The attraction of these dividend stocks isn't limited to their dividends. 
Via The Motley Fool
Topics Intellectual Property
1 Green Flag for AbbVie (ABBV) Stock Right Now
Dividends are powerful portfolio boosters, and AbbVie is a dividend dynamo. 
Via The Motley Fool
Topics Intellectual Property
Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock
 
Via Benzinga
The Best Stocks to Invest $50,000 In Right Now
These stocks have what it takes to succeed over the long run. 
Via The Motley Fool
Topics Artificial Intelligence Government Intellectual Property
AbbVie Logs Best Day In Over 7 Months As Wall Street Cheers Rinvoq Patent Deal Pushing Generics To 2037
Via Stocktwits
Topics Intellectual Property
AbbVie Stock Touches Record High After Company Dismisses Generic Competition For Rinvoq Till 2037: Wells Fargo Terms It A ‘Big Win’
Via Stocktwits
This Is What Whales Are Betting On AbbVie
 
Via Benzinga
Why AbbVie (ABBV) Stock Is Trading Up Today
Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 4.4% in the morning session after the company announced it settled litigation with generic drug manufacturers to extend patent protection for... 
Via StockStory
Topics Intellectual Property
Why AbbVie Stock Is Jumping Today
AbbVie's growth prospects are now more secure thanks to its latest news. 
Via The Motley Fool
AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day
AbbVie stock broke out Thursday after the pharma announced it had inked a deal that will stave off generic Rinvoq until 2037. 
Via Investor's Business Daily
Topics Intellectual Property
AbbVie Seeks To Expand Psychiatry Pipeline By Acquiring Gilgamesh’s Lead Candidate For Up To $1.2B
Via Stocktwits
What's going on in today's session: S&P500 gap up and gap down stocks
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session. 
Via Chartmill
Why Is AbbVie Stock Trading Higher On Thursday?
AbbVie's settlement with generic rivals delays upadacitinib competition in the U.S. until at least 2037, supporting its long-term market presence. 
Via Benzinga
These S&P500 stocks that are showing activity before the opening bell on Thursday.
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday? 
Via Chartmill
Global Growth Hits the Brakes: A Mixed Economic Picture Emerges for 2025 and Beyond
The global economy is bracing for a significant slowdown, with leading financial institutions projecting a challenging landscape for 2025 and the years to follow. A confluence of escalating trade... 
Via MarketMinute
Topics Economy Supply Chain World Trade
1 Reason Every Investor Should Know About AbbVie (ABBV)
This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors. 
Via The Motley Fool
Topics Intellectual Property
3 Dividend Stocks to Double Up on Right Now
Investors can feel good about upping their bets on these great dividend stocks. 
Via The Motley Fool
Topics Energy Intellectual Property
3 Stocks to Buy and Hold Forever
These stocks are built for the long run. 
Via The Motley Fool
Topics Intellectual Property
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
There is more to like than the dividend with these companies. 
Via The Motley Fool
Topics Intellectual Property
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
 
Via Benzinga
1 Safe-and-Steady Stock with Promising Prospects and 2 Facing Headwinds
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Is Healthcare Setting Up to Be a Quiet Leader Into Year-End?
Over $11 billion flowed into the popular healthcare sector ETF XLV in Q2 alone, suggesting smart money is positioning for a potential rebound. 
Via MarketBeat
Topics ETFs
5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer
Selling these dividend stocks isn't on my radar at all. 
Via The Motley Fool
Topics Energy Intellectual Property
The Smartest Dividend Stocks to Buy With $500 Right Now
You won't need a lot of money up front to begin raking in dividends from these great stocks. 
Via The Motley Fool
Topics World Trade
Deal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves
Deal activity this week included PepsiCo, Sycamore and Bain while the bankruptcy front included SSENSE and Dr. Phil. 
Via Benzinga
Topics Bankruptcy
2 Reasons to Watch ABBV and 1 to Stay Cautious
AbbVie currently trades at $207.60 per share and has shown little upside over the past six months, posting a small loss of 0.7%. The stock also fell short of the S&P 500’s 9.2% gain during that... 
Via StockStory
Topics Stocks Supply Chain
As the Market Rotates, This Healthcare ETF Is Leading the Way
Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure. 
Via MarketBeat
Topics ETFs
AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
Via Benzinga
3 Top Stocks to Build Your Portfolio Around
These great businesses can help patient investors beat the market. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
85 86 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.